Hints and tips:
Related Special Reports
...A delay could lead to months of waiting for an outcome while investors are seeking certainty over the future of Grail....
...The consortium includes co-investors in Silver Lake’s funds and CPP Investments, which will provide $1.75bn....
...Past liability management scenarios presented at JPMorgan’s high-yield and leveraged finance event this week included those of Bausch Health and Dish/EchoStar....
...Casino was targeted in 2015 by US short seller Muddy Waters, which argued that it carried more debt in its corporate structure than many investors realised....
...The business is a rare recent success story in a sector battered by falling valuations and divestments from foreign investors....
...That’s the UK watchdog’s job completed though, with investor confidence in the integrity of financial markets restored. So that’s nice. Further reading— NMC Health: presented without comment (FTAV)...
...Italy has banned the production of lab-grown meat in a bid to protect its powerful agricultural industry, and traditional culinary culture....
...At various points over the past 20 years, certain industry groups or companies, whether it be energy or health insurers or something else, have been universally hated and really cheap....
...For investors in the tech sector, however, these disclosures can be a treasure trove. First of all, 13Fs show how investor positions in tech stocks have changed and how private holdings are valued....
...But the holy grail, says Tamara Rogers, chief marketing officer at consumer health company Haleon, is “right person, right time, right message, right context”. “This is a marketer’s dream,” she adds....
...“Small free floats can result in manipulation, but actually most of the time the fundamentals that led to the high redemptions scare away investors and the price collapses.”...
...One thing to start: Cigna is in talks to merge with Humana in a deal that would create a US health insurance giant worth $140bn and provide a significant test for antitrust authorities, according to people...
...Grail, which counted Bill Gates and Jeff Bezos as early investors, is aiming to create a cancer screening test for people without symptoms....
...Losses for those countries equal almost half their collective public health budget, compared with 9 per cent for wealthy countries....
...Shiber’s Project Dragon involved a client with a $100bn valuation facing an activist investor and an unsolicited bid....
...Investors clamoured for junk bonds and loans backing private equity groups’ acquisitions of financial technology company Worldpay and healthcare company Syneos Health....
...The Arm flotation was closely watched as a test of the health of the broader IPO market, and its warm reception — shares jumped 25 per cent on the first day of trading — has bolstered investors’ hopes of...
...On Monday, its boss Francis deSouza resigned after a proxy fight with activist investor Carl Icahn over Illumina’s decision to proceed....
...Influential proxy adviser Glass Lewis has urged investors to vote against the reappointment of the chief executive and chair of Illumina, the world’s largest gene sequencing company, saying the pair have...
...With his new venture, he has decided to cut back on wine and get a personal trainer, a performance coach and a health coach....
...Earlier this year, the company’s chief executive Francis deSouza resigned following a bruising proxy battle with activist investor Carl Icahn, who led a shareholder campaign criticising the “reckless decision...
...Grail’s early investors included Microsoft co-founder Bill Gates and Amazon’s Jeff Bezos....
...The US activist investor branded the deal as reckless and pushed for the departure of Illumina’s longstanding chief executive Francis deSouza, who in June agreed to step down....
...Illumina spun off a new company, Grail, to develop the test, raising more than $2bn from investors including Bill Gates, Jeff Bezos and the Chinese company Tencent....
...Smart reads Succession IRL Rupert Mudoch’s legal troubles, health issues and tumultuous personal life are threatening to unravel his media empire as it enters its next chapter, Vanity Fair writes....
International Edition